EFFICACY AND TOLERABILITY OF INITIATING, OR SWITCHING TO, INFLIXIMAB BIOSIMILAR CT-P13 IN INFLAMMATORY BOWEL DISEASE (IBD): A LARGE SINGLE-CENTRE EXPERIENCE

Ragu Prakash Ratnakumaran  1     Natalie To  1     David J Gracie  1     Christian Selinger  1     Tanya Clark  1     Nicola Carey  2     Grace Dowson     Katherine Leigh     Lynsey Bourner     Alexander Charles Ford     Peter John Hamlin    
1 Leeds Teaching Hospital,Gastroenterology,Leeds,United Kingdom
2 Leeds Teaching Hospit

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing